A real-life Canadian multi-centre study to evaluate efficacy and safety of sofosbuvir containing regimens in liver transplant recipients recurrent hepatitis C patients

Trial Profile

A real-life Canadian multi-centre study to evaluate efficacy and safety of sofosbuvir containing regimens in liver transplant recipients recurrent hepatitis C patients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs Sofosbuvir (Primary) ; Interferon; Ledipasvir; Ribavirin; Simeprevir
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2015 New trial record
    • 26 Apr 2015 Interim results (n = 120) presented at the 50th Annual Meeting of the European Association for the Study of the Liver.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top